Hookipa Pharma
is a New York-based clinical-stage biopharma company that researches and develops novel immunotherapies for the treatment of cancer and infectious diseases... Read moreHookipa Pharma
is a New York-based clinical-stage biopharma company that researches and develops novel immunotherapies for the treatment of cancer and infectious diseases... Read more
News
Feb 04, 2026
Nasdaq
Hookipa Pharma: HOOKIPA Pharma T0 Sell Oncology Assets HB-200 And HB-700 To NeoTrail Therapeutics
Jul 20, 2025
Life Care News
Hookipa Pharma: HOOKIPA Pharma Announces Intention to Voluntarily Delist and Deregister its Common Stock
Jul 18, 2025
Investing.com
Hookipa Pharma: HOOKIPA Pharma Inc. Halted, News Pending By Investing.com
Jul 18, 2025
Seeking Alpha
Hookipa Pharma: HOOKIPA Pharma to delist from Nasdaq and liquidate following Gilead asset sale
May 15, 2025
Benzinga
Hookipa Pharma: HOOKIPA Pharma Q1 EPS $(1.23) Misses $(0.62) ...
Mar 03, 2025
Owler
Hookipa Pharma, Inc.: Hookipa Pharma's employee count changed from 151 in Feb 2024 to 87 in Dec 2024
Feb 20, 2025
GlobeNewswire
Press Release: Hookipa Pharma : HOOKIPA Pharma Inc. ("HOOKIPA") Statement regarding potential combination for Poolbeg Pharma plc ("Poolbeg")
Jan 07, 2025
Proactive Investors
Hookipa Pharma: Gilead backs proposed Poolbeg Pharma's proposed tie-up with HOOKIPA
Jan 02, 2025
Irish Examiner
Hookipa Pharma: Poolbeg Pharma to merge with Austrian biotech company
Nov 15, 2024
Seeking Alpha
Hookipa Pharma: HOOKIPA Pharma GAAP EPS of -$1.10, revenue of $4.7M
Hookipa Pharma Competitors
1
2
3
4
5
6
7
8
9
10